my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
25-Sep-2020 Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination. In this process, they have also disco ... more
25-Sep-2020 The cells that make up our body are tiny, each of them measuring only micrometers in diameter. The ensemble of chromosomal DNA molecules that encode the genome, on the other hand, measures almost 2 meters. In order to fit into cells, chromosomal DNA is folded many times. But the DNA is not ... more
25-Sep-2020 The molecular bases of the placebo effect are poorly understood. A team led by LMU researcher Karin Meissner has now studied the phenomenon in the context of nausea, and identified specific proteins that correlate with its favorable impact. The placebo effect appears to work wonders. In cer ... more
25-Sep-2020 As the COVID-19 pandemic rages on, researchers are working overtime to develop vaccines and therapies to thwart SARS-CoV-2, the virus responsible for the disease Many efforts focus on the coronavirus spike protein, which binds the angiotensin-converting enzyme 2 (ACE2) on human cells to all ... more
24-Sep-2020 By far the most important process in cell development is how cells divide and then enlarge in order to multiply. A research team headed by Freiburg medical scientist Prof. Dr. Robert Grosse has now discovered that bundled fibers of actin within a cell nucleus play an important part in how t ... more
24-Sep-2020 The diverse work of Mainz-based physicists in the field of nuclear magnetic resonance is being boosted by a new highly application-oriented approach: In October 2020, Dr. Danila Barskiy will join Johannes Gutenberg University Mainz (JGU) to set up a group focusing on nuclear magnetic resona ... more
23-Sep-2020 Evonik and Siemens Energy commissioned a pilot plant sponsored by the German Federal Ministry of Education and Research (BMBF) that uses carbon dioxide and water to produce chemicals. The necessary energy is supplied by electricity from renewable sources. The pilot plant is located in Marl, ... more
23-Sep-2020 Illumina, Inc. announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction. In addition, GRAIL stockholders will receive future payments representing a tiered single digit perc ... more
23-Sep-2020 Resolving genomes, particularly plant genomes, is a very complex and error-prone task. This is because there are several copies of all of the chromosomes and they are very alike. A team of bioinformatics researchers from Heinrich Heine University Düsseldorf (HHU) has now developed a softwar ... more
22-Sep-2020 Scientists and researchers at the U.S. Naval Research Laboratory and National Center for Advancing Translational Sciences (NCATS), submitted their findings to ACS Nano on their collaboration to develop SARS-CoV-2 nanoparticle probes that are used to study fundamental interactions between SA ... more
23-Sep-2020 Resolving genomes, particularly plant genomes, is a very complex and error-prone task. This is because there are several copies of all of the chromosomes and they are very alike. A team of bioinformatics researchers from Heinrich Heine University Düsseldorf (HHU) has now developed a softwar ... more
16-Sep-2020 Bruker Corporation announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques. Bruker’s glo ... more
21-Aug-2020 Bacteria show a wide range of capabilities in withstanding antibiotic treatment or attack by our immune system, which are great challenges in infection research. Scientists at the Würzburg-based Helmholtz Institute for RNA-based Infection Research (HIRI), a site of the Helmholtz Centre for ... more
13-Aug-2020 analytica gets a digital extension. With the new format analytica virtual, the world’s leading trade fair for laboratory technology, analysis and biotechnology also enables those exhibitors and visitors to participate who due to travel restrictions cannot come to Munich. In addition, parts ... more
11-Aug-2020 An international consortium succeeded in tracking the genesis and spread of new reassortants of avian influenza viruses by the use of mathematical analyses. This large-scale international study has now been published in the scientific journal PNAS (Proceedings of the National Academy of Sci ... more
04-Aug-2020 COVID-19 has changed the lives of millions and even billions of people around the world. The disease is caused by SARS coronavirus 2 (SARS-CoV-2), an RNA virus, i.e. a virus that uses RNA to store its genetic information. In order to confront it, we must have a detailed understanding of the ... more
03-Aug-2020 Tea (Camellia sinensis) is one of the world's most popular drinks with a wide range of flavours and health benefits. Researchers from Huazhong Agricultural University of Wuhan (China), Forschungszentrum Jülich, Heinrich Heine University Düsseldorf and the Max Planck Institute of Molecular P ... more
24-Jul-2020 For the first time, the raw genetic material that codes for bats’ unique adaptations and superpowers such as the ability to fly, to use sound to move effortlessly in complete darkness, to survive and tolerate deadly diseases, to resist ageing and cancer - has been fully revealed. Bat1K, a g ... more
23-Jul-2020 The formation of four-stranded DNA has been tracked in living human cells, allowing scientists to see how it works, and its possible role in cancer. DNA usually forms the classic double helix shape discovered in 1953 - two strands wound around each other. Several other structures have been ... more
21-Jul-2020 An interdisciplinary team from Frankfurt and Jena has developed a kind of bait with which to fish protein complexes out of mixtures. Thanks to this “bait”, the desired protein is available much faster for further examination in the electron microscope. The research team has christened this ... more
23-Sep-2020 Evonik and Siemens Energy commissioned a pilot plant sponsored by the German Federal Ministry of Education and Research (BMBF) that uses carbon dioxide and water to produce chemicals. The necessary energy is supplied by electricity from renewable sources. The pilot plant is located in Marl, ... more
22-Sep-2020 Inflazome announced that it has closed a share purchase agreement with Roche in which Inflazome’s shareholders received an upfront payment of €380 million, and are eligible to receive additional contingent payments to be made based on the achievement of certain predetermined milestones. I ... more
21-Sep-2020 So-called “bioplastics” are marketed as an environmentally friendly alternative to conventional, petroleum-based plastics. They can be made from renewable feedstock, might be bio-degradable or even both. The question is however if these biomaterials are safer than conventional plastics with ... more
17-Sep-2020 Merck expects to deliver continued profitable growth in the coming years despite a challenging market environment. Today at its virtual Capital Markets Day, the company presented to analysts and investors the progress made in realizing the growth and expansion phase of its strategy for the ... more
15-Sep-2020 The idea is that bacteria shouldn’t only convert waste products into valuable chemicals, but also draw energy from them. After all, they too can be reused for subsequent processes. This vision is what drives Professor Dirk Tischler, who heads the Microbial Biotechnology research group at Ru ... more
15-Sep-2020 ETH researchers have discovered that they can use light-sensitive molecules to switch genetic networks on and off as required. Their finding gives rise to an easy method for dynamically controlling biotechnological substance production. Tetracycline (Tc), an antibiotic, and its derivative ... more
10-Sep-2020 Merck announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA. This investment will allow large-scale manufacturing of increasingly potent compounds for therapies that have the potential to treat cancer. Co ... more
09-Sep-2020 Leather is used as a durable and flexible material in many aspects of everyday life including furniture and clothing. Leather substitutes derived from fungi are considered to be an ethical and environmentally friendly alternative to traditional bovine leather. An international team led by m ... more
08-Sep-2020 BioNTech SE and Pfizer Inc. announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 2/3 clinical trial in Germany for their BNT162b2 vaccine candidate. The study in Germany is part of the global pivotal Phase 2/3 program BioNTech and Pfizer initiate ... more
08-Sep-2020 A new application of the CRISPR/Cas molecular scissors promises major progress in crop cultivation. At Karlsruhe Institute of Technology (KIT), researchers from the team of molecular biologist Holger Puchta have succeeded in modifying the sequence of genes on a chromosome using CRISPR/Cas. ... more
23-Sep-2020 Illumina, Inc. announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction. In addition, GRAIL stockholders will receive future payments representing a tiered single digit perc ... more
18-Sep-2020 QIAGEN N.V. announced the acquisition of the remaining 80.1% of diagnostics instruments company NeuMoDx Molecular, Inc. for $248 million in cash. The move rounds out QIAGEN’s portfolio of automated molecular testing solutions based on the proven PCR technology. The transaction was completed ... more
18-Sep-2020 Researchers at Helmholtz Zentrum München and the Technical University of Munich (TUM) have developed the world’s smallest ultrasound detector. It is based on miniaturized photonic circuits on top of a silicon chip. With a size 100 times smaller than an average human hair, the new detector c ... more
10-Sep-2020 A serious illness is often the result of a single genetic defect. But given that two healthy people already have around three million differences in their genetic make-up, it is no easy task to pick out the one disease-causing deviation from the many harmless gene variants. Scientists at th ... more
09-Sep-2020 Hundreds of researchers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare. In a perspective in Nature and the LifeTime Strategic Research Agenda they now present a roadmap of how to leverage the latest scientific ... more
04-Sep-2020 The combination of a biomolecule and a metal complex can target, bind, mark and damage cancer cells. A German-Spanish team has manufactured such a theranostic agent that visualises tumour cells by irradiation with visible light, and proved its effectiveness against lung cancer cells. Andres ... more
02-Sep-2020 This year, Messe München is hosting the world’s leading trade fair for laboratory technology, analysis and biotechnology as a virtual event. The new format analytica virtual will enable exhibitors to book digital trade fair booths for October 19 to 23. Furthermore, it offers all customers a ... more
02-Sep-2020 As COVID-19 continues to spread, bottlenecks in supplies and laboratory personnel have led to long waiting times for results in some areas. In a new study, University of Illinois, Urbana-Champaign researchers have demonstrated a prototype of a rapid COVID-19 molecular test and a simple-to-u ... more
31-Aug-2020 Aignostics, a spin-off from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) pioneering computational pathology for pharmaceutical research and diagnostics, has announced the closing of a €5 M seed round funding. Boehringer Ingelheim Venture Fund (BIVF) led the ... more
19-Aug-2020 A research team from the University Hospital at Ruhr-Universität Bochum (RUB) has developed a test that provides information on the immune response to the novel coronavirus in patients who need to take immunosuppressive drugs. This is necessary, for instance, following an organ transplantat ... more
02-Sep-2020 This year, Messe München is hosting the world’s leading trade fair for laboratory technology, analysis and biotechnology as a virtual event. The new format analytica virtual will enable exhibitors to book digital trade fair booths for October 19 to 23. Furthermore, it offers all customers a ... more
26-Aug-2020 The globally active Eppendorf Group was once again able to increase its consolidated revenue in the first half of 2020. Despite the global restrictions necessitated by the coronavirus pandemic, revenue grew by 6.6% to €403.7 million (prior-year: €378.5 million). Operating profit (EBIT) in t ... more
13-Aug-2020 analytica gets a digital extension. With the new format analytica virtual, the world’s leading trade fair for laboratory technology, analysis and biotechnology also enables those exhibitors and visitors to participate who due to travel restrictions cannot come to Munich. In addition, parts ... more
17-Jul-2020 Based on the strong performance of the Bioprocess Solutions Division in the first half of 2020 as well as on high demand also expected to continue for the rest of the current fiscal year, Sartorius raised its full-year sales and earnings guidance for this division and thus for the entire Gr ... more
14-Jul-2020 InnoME, Gmbh and Etaluma, Inc. announced a partnership to bring entry level incubator cell imaging to the Americas. Etaluma will exclusively offer InnoME’s zenCell technology as the “lumanette”. The lumanette provides 24 individual 10x imagers for very simple time lapse experiments in 24 a ... more
10-Jul-2020 LGC announced the acquisition of The Native Antigen Company (NAC), supplier of high quality infectious disease antigens and antibodies. NAC is a developer, manufacturer and supplier of critical reagents to the in vitro diagnostic (IVD), pharmaceutical and academic sectors. It offers a compr ... more
30-Jun-2020 After the postponement to the fall, there are now increasing signs for a success of analytica in October. The number of exhibitors has currently almost reached the level of the previous event. Most recently, the Bavarian State Government has cleared the way for analytica: From September 01 ... more
20-Mar-2020 Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. A corresponding agreement was signed by both companies in Tokyo. The acquisition marks a targeted step by Hamburg-based Eppendorf AG ... more
09-Mar-2020 Due to the increasing spread of the coronavirus (COVID-19) in Europe and on the basis of the recommendations of the Bavarian State Government as well as of the responsible health authorities, Messe München feels compelled to postpone analytica 2020. This measure is taken in consultation wit ... more
26-Feb-2020 Cellbox Solutions announces the expansion of its Board of Directors and the appointment of a new CEO - Wolfgang Kintzel will start as Chief Executive Officer effective March 1, 2020. The founder Prof. Kathrin Adlkofer will support the board in the function as COO. Wolfgang Kintzel has an ex ... more
22-Sep-2020 Inflazome announced that it has closed a share purchase agreement with Roche in which Inflazome’s shareholders received an upfront payment of €380 million, and are eligible to receive additional contingent payments to be made based on the achievement of certain predetermined milestones. I ... more
17-Sep-2020 With the current pandemic crisis, the lack of worldwide vaccine manufacturing capacity has become a serious concern. ContiVir, a spin-off project at the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has successfully produced a virus-like particle as a COVID-19 va ... more
17-Sep-2020 Merck expects to deliver continued profitable growth in the coming years despite a challenging market environment. Today at its virtual Capital Markets Day, the company presented to analysts and investors the progress made in realizing the growth and expansion phase of its strategy for the ... more
16-Sep-2020 Seattle Genetics, Inc. and Merck, known as MSD outside the United States and Canada, announced two new strategic oncology collaborations. The companies will globally develop and commercialize Seattle Genetics’ ladiratuzumab vedotin, an investigational antibody-drug conjugate (ADC) targeting ... more
15-Sep-2020 Gilead Sciences, Inc. and Immunomedics announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Immunomedics for $88.00 per share in cash. The transaction, which values Immunomedics at approximately $21 billion, was unanimously approved by ... more
14-Sep-2020 The Supervisory Board of Bayer AG has unanimously decided to extend the contract of Werner Baumann, Chairman of the Board of Management, until April 30, 2024. Before the extension, Baumann’s contract would have expired at the 2021 Annual Stockholders’ Meeting. Baumann, 57, has worked for Ba ... more
08-Sep-2020 BioNTech SE and Pfizer Inc. announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 2/3 clinical trial in Germany for their BNT162b2 vaccine candidate. The study in Germany is part of the global pivotal Phase 2/3 program BioNTech and Pfizer initiate ... more
08-Sep-2020 Many production facilities (e.g. plastic manufacturers, pharma companies, and others) use nanocatalysts that contain palladium--an expensive component that is not sustainably produced. A chemist from RUDN University found a way to reduce palladium consumption and to make its manufacture mor ... more
07-Sep-2020 CureVac N.V. has received notification from the German Federal Ministry of Education and Research (BMBF) that CureVac is expected receive up to 252 million euros to support the development of its COVID-19 vaccine candidate. In July 2020, CureVac had applied to a grant as part of a special p ... more
31-Aug-2020 Triumvira Immunologics Inc. (“Triumvira”), a privately-held biopharmaceutical company developing a novel platform for engineering T-cells to attack cancers, successfully completed a USD 55 million Series A financing round. The financing was co-led by Leaps by Bayer, the impact investment un ... more
25-Sep-2020 Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination. In this process, they have also disco ... more
25-Sep-2020 The molecular bases of the placebo effect are poorly understood. A team led by LMU researcher Karin Meissner has now studied the phenomenon in the context of nausea, and identified specific proteins that correlate with its favorable impact. The placebo effect appears to work wonders. In cer ... more
25-Sep-2020 As the COVID-19 pandemic rages on, researchers are working overtime to develop vaccines and therapies to thwart SARS-CoV-2, the virus responsible for the disease Many efforts focus on the coronavirus spike protein, which binds the angiotensin-converting enzyme 2 (ACE2) on human cells to all ... more
22-Sep-2020 Scientists and researchers at the U.S. Naval Research Laboratory and National Center for Advancing Translational Sciences (NCATS), submitted their findings to ACS Nano on their collaboration to develop SARS-CoV-2 nanoparticle probes that are used to study fundamental interactions between SA ... more
22-Sep-2020 Prolonged sleep deprivation can lead to severe health problems in humans and other animals. But why is sleep so vital to our health? A UCLA-led team of scientists has answered this question and shown for the first time that a dramatic change in the purpose of sleep occurs at the age of abou ... more
22-Sep-2020 Researchers at the University of Bern have discovered a mechanism in the body’s own immune system which is responsible for the maturation and activation of immune cells. In the fight against skin cancer, the results have the potential to help immunotherapies succeed, even in patients for wh ... more
21-Sep-2020 A genetic predisposition to late-onset Alzheimer’s disease affects how the brains of young adults cope with certain memory tasks. Researchers from the German Center for Neurodegenerative Diseases (DZNE) and the Ruhr-Universität Bochum report on this in the scientific journal “Current Biolog ... more
21-Sep-2020 Researchers at Uppsala University have developed a new method to determine - rapidly, easily and cheaply - how effective two antibiotics combined can be in stopping bacterial growth. The new method is simple for laboratories to use and can provide greater scope for customising treatment of ... more
18-Sep-2020 In a seven-year research effort, an international team of scientists has clarified the cause for certain genetic forms of Parkinson’s disease, and has identified potential pharmacological treatments. The interdisciplinary research team, led by Prof. Rejko Krüger, of the Luxembourg Centre fo ... more
17-Sep-2020 Scientists from the Institute of Molecular Biology of the Austrian Academy of Sciences and the University of British Columbia have discovered a major role of the protein JAGN1 in antibody production and the body’s ability to mount a defense against pathogens, including viruses. Antibodies ... more
Highly effective antibodies against the coronavirus were identified
Glycans in the SARS-CoV-2 spike protein play active role in infection
Danila Barskiy receives Sofja Kovalevskaja Award to develop low-cost portabl ...
For a climate-friendly industry: Using carbon dioxide and hydrogen as raw ma ...
Method to safely study COVID-19, other contagious diseases developed
Increasing the effectiveness of immunotherapy against skin cancer
Are bioplastics and plant-based materials safer than conventional plastics?
Stem cell research delivers new points of attack against Parkinson’s disease
Why do hospital germs bind more strongly to certain surfaces than to others?
Evonik and Siemens Energy put pilot plant into operations
23-Sep-2020 Evonik and Siemens Energy commissioned a pilot plant sponsored by the German Federal Ministry of Education and Research (BMBF) that uses carbon dioxide and water to produce chemicals. The necessary energy is supplied by electricity from renewable sources. The pilot plant is located in Marl, ... more
Quick, efficient and scalable vaccine manufacturing: virus-like particle developed and produced
17-Sep-2020 With the current pandemic crisis, the lack of worldwide vaccine manufacturing capacity has become a serious concern. ContiVir, a spin-off project at the Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, has successfully produced a virus-like particle as a COVID-19 va ... more
Regulatory Approval From Paul-Ehrlich-Institut to Commence German Part of Global Phase 2/3 Trial Received
08-Sep-2020 BioNTech SE and Pfizer Inc. announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the Phase 2/3 clinical trial in Germany for their BNT162b2 vaccine candidate. The study in Germany is part of the global pivotal Phase 2/3 program BioNTech and Pfizer initiate ... more
Evonik and Siemens Energy put pilot plant into operations
23-Sep-2020 Evonik and Siemens Energy commissioned a pilot plant sponsored by the German Federal Ministry of Education and Research (BMBF) that uses carbon dioxide and water to produce chemicals. The necessary energy is supplied by electricity from renewable sources. The pilot plant is located in Marl, ... more
Launch new era of cancer detection
23-Sep-2020 Illumina, Inc. announced they have entered into a definitive agreement under which Illumina will acquire GRAIL for cash and stock consideration of $8 billion upon closing of the transaction. In addition, GRAIL stockholders will receive future payments representing a tiered single digit perc ... more
Orally available NLRP3 inflammasome inhibitors to address clinical unmet needs across a wide variety of inflammatory diseases
22-Sep-2020 Inflazome announced that it has closed a share purchase agreement with Roche in which Inflazome’s shareholders received an upfront payment of €380 million, and are eligible to receive additional contingent payments to be made based on the achievement of certain predetermined milestones. I ... more
Does the cost correspond to the particular drug’s effectiveness in combating the disease?
05-May-2020 Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international UZH study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit. The researchers are therefore calling for the clin ... more
13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more
18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more
Berlin scientists lay basis for a passive vaccination
25-Sep-2020 Researchers at the German Center for Neurodegenerative Diseases (DZNE) and Charité - Universitätsmedizin Berlin have identified highly effective antibodies against the coronavirus SARS-CoV-2 and are now pursuing the development of a passive vaccination. In this process, they have also disco ... more
Groundbreaking method to map contact points between replicated DNA molecules, thereby elucidating how the genome is folded inside the nucleus of human cells
25-Sep-2020 The cells that make up our body are tiny, each of them measuring only micrometers in diameter. The ensemble of chromosomal DNA molecules that encode the genome, on the other hand, measures almost 2 meters. In order to fit into cells, chromosomal DNA is folded many times. But the DNA is not ... more
First study of the placebo effect at the molecular level, in the context of the relief of nausea
25-Sep-2020 The molecular bases of the placebo effect are poorly understood. A team led by LMU researcher Karin Meissner has now studied the phenomenon in the context of nausea, and identified specific proteins that correlate with its favorable impact. The placebo effect appears to work wonders. In cer ... more
Contract until the end of April 2024
14-Sep-2020 The Supervisory Board of Bayer AG has unanimously decided to extend the contract of Werner Baumann, Chairman of the Board of Management, until April 30, 2024. Before the extension, Baumann’s contract would have expired at the 2021 Annual Stockholders’ Meeting. Baumann, 57, has worked for Ba ... more
Dr. Igor Splawski as Chief Scientific Officer appointed
05-Aug-2020 CureVac announced that Dr. Franz-Werner Haas, previously acting Chief Executive Officer and Chief Operating Officer (COO), has been appointed Chief Executive Officer (CEO). Before Dr. Haas joined CureVac in June 2012, he worked as Vice President Operations and Chief Compliance Officer of SY ... more
Dr. Batra succeeds Christopher O’Connell
17-Jul-2020 Waters Corporation announced that Udit Batra, Ph.D. has been named the Company’s President and Chief Executive Officer, effective September 1, 2020. He will also join Waters’ Board of Directors at that time. Dr. Batra succeeds Christopher O’Connell who will remain in his current roles as Pr ... more
From today’s perspective targeted smaller to medium-sized acquisitions after 2022 more likely than major transformative deals
17-Sep-2020 Merck expects to deliver continued profitable growth in the coming years despite a challenging market environment. Today at its virtual Capital Markets Day, the company presented to analysts and investors the progress made in realizing the growth and expansion phase of its strategy for the ... more
Aignostics Raises €5 Million Seed Round
31-Aug-2020 Aignostics, a spin-off from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) pioneering computational pathology for pharmaceutical research and diagnostics, has announced the closing of a €5 M seed round funding. Boehringer Ingelheim Venture Fund (BIVF) led the ... more
Bayer and Northpond Ventures lead USD 55 million Series A financing round
31-Aug-2020 Triumvira Immunologics Inc. (“Triumvira”), a privately-held biopharmaceutical company developing a novel platform for engineering T-cells to attack cancers, successfully completed a USD 55 million Series A financing round. The financing was co-led by Leaps by Bayer, the impact investment un ... more
Evonik and Siemens Energy put pilot plant into operations
23-Sep-2020 Evonik and Siemens Energy commissioned a pilot plant sponsored by the German Federal Ministry of Education and Research (BMBF) that uses carbon dioxide and water to produce chemicals. The necessary energy is supplied by electricity from renewable sources. The pilot plant is located in Marl, ... more
Merck to Acquire $1 Billion Equity Stake in Seattle Genetics Common Stock
16-Sep-2020 Seattle Genetics, Inc. and Merck, known as MSD outside the United States and Canada, announced two new strategic oncology collaborations. The companies will globally develop and commercialize Seattle Genetics’ ladiratuzumab vedotin, an investigational antibody-drug conjugate (ADC) targeting ... more
Milestone potential of more than € 150 m per product
19-Aug-2020 Evotec SE and Novo Nordisk announced a strategic collaboration on the discovery and development of innovative therapeutics for patients with chronic kidney disease. Evotec and Novo Nordisk will jointly identify and develop novel targets based on comprehensive medical and molecular data sets ... more
Strengthening LGC'S offer to the IVD sector
10-Jul-2020 LGC announced the acquisition of The Native Antigen Company (NAC), supplier of high quality infectious disease antigens and antibodies. NAC is a developer, manufacturer and supplier of critical reagents to the in vitro diagnostic (IVD), pharmaceutical and academic sectors. It offers a compr ... more
05-Feb-2020 Domain Therapeutics announced that it has been granted a patent in the US and in Europe covering a novel family of biosensors. The patent, entitled ‘Biosensors for monitoring biomolecule localization and trafficking in cells’, was initially filed by Prof. Michel Bouvier and his team and i ... more
18-Apr-2019 Personal drug delivery or nano-robotic systems could be a key concept for future medical applications. In this context, scientists around David Ng (Department of Prof. Tanja Weil) of the Max Planck Institute for Polymer Research (MPI-P) have recently developed a technology to customize the ... more
27-Nov-2019 Merck announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases, bringing Merck’s number of patents to 22 worldwide. “Paired nickases represent a significant step in incre ... more
15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more
05-Mar-2019 Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for diffi ... more
Race for COVID-19 vaccine
13-Jul-2020 In the first half of this year, the transaction volume of mergers and acquisitions in the chemical and life sciences industries has decreased dramatically. The volume of deals announced in the first six months is only $84 billion. Compared to the previous year (389 billion dollars), this is ... more
'Embarrassing' or stigmatized cancers like lung and liver are underfunded
23-Jul-2019 Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new Northwestern Medicine study that examined the distribution of nonprofit research funding in 2015 across cancer types. Colon, endometrial, liver and bile duct, cervical, ovaria ... more
22-Jul-2019 According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 258 Mn in terms of value in 2018. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18 ... more
15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more
Toxicity testing of microparticles and poorly soluble liquids in the water environment
15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more
11-Oct-2018 Strategic investment in 15 promising technologies could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events. This subset of emerging technologies and their potential application are the focus of a new report, Tech ... more
Significant increase in demand due to African swine fever and corona pandemic
16-Sep-2020 Due to the continuous strong demand for disinfectants, specialty chemicals company LANXESS is planning to expand its production capacity for Oxone monopersulfate by around 50 percent. To this end, the company intends to invest a lower double-digit million euro sum in its production facility ... more
Creates one of the largest single-digit nanogram containment manufacturing facilities for high-potent active pharmaceutical ingredient (HPAPI) production
10-Sep-2020 Merck announced a € 59 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin, USA. This investment will allow large-scale manufacturing of increasingly potent compounds for therapies that have the potential to treat cancer. Co ... more
29-Jul-2020 Sandoz, the Novartis generics and biosimilars division, is pleased to announce plans for a joint investment, together with the Austrian federal government, to strengthen the long-term future of integrated antibiotics manufacturing in Europe. Sandoz CEO Richard Saynor said: “This plan is a g ... more
Around 250 vacancies at all locations by the end of 2019
26-Apr-2019 The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company and is an important component of Eppendorf's growth strategy. "Eppendorf is growing strongl ... more
12-Apr-2019 Income and social status have an increasing effect on life expectancy in Germany. On average, men with very low retirement pay die five years earlier than those who are much better off. Poverty shortens life. According to a study by researchers at the Max Planck Institute for Demographic Re ... more
28-Feb-2019 In the study "Leading Employers Germany 2019", the Berlin-based manufacturer of high-tech laboratory measuring instruments KNAUER was ranked as one of the best employers for the second time. This makes KNAUER one of the companies with the best ratings in an independent meta-study conducted ... more
USA
Germany
United Kingdom
Switzerland
France
Belgium
Canada
Sweden
Netherlands
Austria
Japan
Denmark
Australia
Spain
China
Israel
Finland
Norway
Singapore
Italy
Korea, Republic of (South Korea)
India
Russian Federation
Ireland
Brazil
Luxembourg
Poland
New Zealand
Viet Nam
Malaysia
South Africa
Taiwan
© 1997-2020 LUMITOS AG, All rights reserved
